COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHLOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE

Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age1-28
SponsorUniversity of Child Health Sciences and Children's Hospital, Lahore

About this trial

COMPARISON OF OUTCOME OF HYPOXIC ISCHEMIC ENCEPHALOPATHY MANAGED WITH COMBINATION OF MAGNESIUM SULPHATE AND MELATONIN VERSUS MAGNESIUM SULPHATE ALONE Participants of group A will have 3 doses of MgSO4 infusion at rate of 250mg/kg per day intravenous over 1hour on day 0,1,2 Participants of group B will have 5 doses of Melatonin 10mg/kg for 5days along with MgSO4. They will undergo reassessment of arterial PH and serum LDH after completion of therapy. They will be followed for length of hospital stay and time until feed is initiated.

Eligibility criteria

Qualifiers

Both genders

Born at term i.e >37weeks gestation

With APGAR score<5 at 1min

Umblical artery acidemia(PH<7 or base deficit>12mmol/L

Disqualifiers

With congenital anamolies

Intrauterine growth retadation

suspicion of neonatal sepsis

Congenital heart disese and those with IEM.

Trial design

Treatments tested in this trial

  • MgSO4 (seizure prevention)
  • Melatonin , Mgso4

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations